Medical Condition News

RSS

Cardiologists recommend tips to prevent heart disease

There's a lot you can do to reduce your risk of heart disease and improve your chances for a longer, healthier life. Cardiologists from The Polyclinic in Seattle recommend that you first, learn more about some of the risk factors for heart disease.

6 Feb 2010

AMAG Pharmaceuticals releases safety update on Feraheme Injection

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.

6 Feb 2010

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

Sorin Group, a global leader in the treatment of cardiovascular disease, announced today U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym™ CRT Model 8750. Featuring a new, state-of-the-art battery technology, Paradym™ CRT delivers 37 Joules, the highest energy of any implantable cardiac defibrillator (ICD) currently available.

6 Feb 2010

HHS donates more than $119 million to support health promotion initiatives

The U.S. Department of Health and Human Services (HHS) today awarded more than $119 million to states and U.S. territories to support public health efforts to reduce obesity, increase physical activity, improve nutrition, and decrease smoking-the four most important actions for combating chronic diseases and promoting health

6 Feb 2010

Strativa Pharmaceuticals' Zuplenz NDA: FDA issues complete response letter

Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug application (NDA) for Zuplenz® (ondansetron) oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.

6 Feb 2010

A program to raise awareness of heart disease

Members of the largest growing women’s organization, the Red Hat Society, kick off the RHS Go Red for Women Program today by trading in their purple dresses for red. The program, which aims to raise awareness of heart disease, the number one cause of death of women in America, encourages Red Hatters from sea to sea to follow the beat and match their hat to their dress.

6 Feb 2010

Stigma and social stereotyping of obesity impacts individuals' beliefs and behaviours

A Monash University-led nationwide study into the health beliefs and behaviours of obese people has found that the more severely obese a person is, the less likely they feel they can reduce their weight.

6 Feb 2010

Study calls for individualized therapeutic interventions for MS patients

Fewer African Americans than Caucasians develop multiple sclerosis (MS), statistics show, but their disease progresses more rapidly, and they don't respond as well to therapies, a new study by neurology researchers at the University at Buffalo has found.

6 Feb 2010

Biotechnology: The next medical revolution

A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease.

5 Feb 2010

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.

5 Feb 2010

Teens with suicidal thoughts and depressive symptoms can benefit from family therapy

Adolescents with suicidal thoughts and elevated depression had stronger and faster reduction of symptoms when treated with family therapy than with standard treatment in the community.

5 Feb 2010

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime’s commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.

5 Feb 2010

10 helpful tips to safeguard Alzheimer's patients

An ID bracelet, like the one offered through the Alzheimer's Association's MedicAlert + Safe Return program, helps the police or a Good Samaritan get a missing person back home safely or medical attention.

5 Feb 2010

P.A.D. Task Force Committee: BioMedix Vascular Solutions invited to participate

BioMedix Vascular Solutions, Inc. announced today that John Romans, CEO and Meg Heim, RN, Vice President of Marketing have been invited to participate as members of the P.A.D. Task Force Committee on behalf of the Governor of California, Arnold Schwarzenegger, The California Podiatric Medical Association and the California Department of Chronic Disease and Injury Prevention (CDPH). The committee will meet today, February 4th, 2010 in the California State Capitol, Governors conference room.

5 Feb 2010

Intrathecal drug delivery cost effective for chronic pain treatments

Estimates of pain care treatment costs exceed $1 billion annually in the United States. Today at the American Academy of Pain Medicine's 26th Annual Meeting two abstracts looked at the issue. One evaluated intrathecal drug delivery (a targeted medicine delivery system) that could save costs over time. The other analyzed the differences between the costs of treatment for chronic pain treatments.

5 Feb 2010

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Despite evidence and guidelines supporting the value of screening for this disease, rates of screening for colorectal cancer are consistently lower than those for other types of cancer, particularly breast and cervical.

5 Feb 2010

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

In 2009 a student research project investigating a low frequency therapy for temporary tinnitus was joint runner-up in the 2009 BT Young Scientist and Technology Exhibition, held in Dublin, Ireland. The student research project which has now evolved into a web-based company, Restored Hearing (www.restoredhearing.ie) was one of the companies which showcased recently at the 2010 exhibition.

5 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

Project Lifesaver International, Xanboo to offer medical facilities to help people with cognitive disorder

Project Lifesaver International, a non-profit organization specializing in training public safety agencies on search and rescue programs to help individuals with cognitive conditions that wander, announced today they will be teaming with Xanboo, a wireless equipment company that supplies a wide variety of intrusion and security products, including indoor and outdoor cameras, control of lighting, door/window censors, and other security products.

5 Feb 2010

Substance use disorder treatment for workers without health insurance promotes safe and productive workplaces

An estimated 3 million full-time workers in America without health insurance (16.3 percent of all full-time workers without health care insurance) needed substance use treatment in the past year according to a national survey conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA). Levels of need were particularly high among those in this category who were aged 18 to 25 (24.4 percent) and males (19.2 percent).

5 Feb 2010

Medical Condition News

Cardiologists recommend tips to prevent heart disease

AMAG Pharmaceuticals releases safety update on Feraheme Injection

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

HHS donates more than $119 million to support health promotion initiatives

Strativa Pharmaceuticals' Zuplenz NDA: FDA issues complete response letter

A program to raise awareness of heart disease

Stigma and social stereotyping of obesity impacts individuals' beliefs and behaviours

Study calls for individualized therapeutic interventions for MS patients

Biotechnology: The next medical revolution

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

Teens with suicidal thoughts and depressive symptoms can benefit from family therapy

BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients

10 helpful tips to safeguard Alzheimer's patients

P.A.D. Task Force Committee: BioMedix Vascular Solutions invited to participate

Intrathecal drug delivery cost effective for chronic pain treatments

NIH panel convened to increase the use and quality of colorectal cancer screening in the U.S.

Low frequency therapy for temporary tinnitus: Student research project evolves into web-based company

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Project Lifesaver International, Xanboo to offer medical facilities to help people with cognitive disorder

Substance use disorder treatment for workers without health insurance promotes safe and productive workplaces

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News